Skip to main content
Michael Garshick, MD, Cardiology, New York, NY

MichaelSethGarshickMD

Cardiology • New York, NY

Adult Congenital Heart Disease

Physician

Join to view full profile

Dr. Garshick is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Garshick's full profile

Already have an account?

  • Office

    530 1st Ave
    Ste 4F
    New York, NY 10016
    Phone+1 212-263-0855
    Fax+1 212-263-7908

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Cardiovascular Disease, 2014 - 2017
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2011 - 2014
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 2011

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2012 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Inductee Alpha Omega Alpha Honor Medical Society, 2011

Publications & Presentations

PubMed

Lectures

  • Activated Platelets Induce Endothelial Activation in Patients With Psoriasis 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • The Contribution of Gastrointestinal Microbiome Alterations to Atherosclerotic Plaque Regression 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Activated Platelets Induce Endothelial Activation in Patients With Psoriasis 
    2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Press Mentions

  • Vigilance Needed in Gout Treatment to Reduce CVD Risks
    Vigilance Needed in Gout Treatment to Reduce CVD RisksMay 17th, 2024
  • Elevated PCSK9 Levels Associated with Psoriasis Suggest New Treatment Target
    Elevated PCSK9 Levels Associated with Psoriasis Suggest New Treatment TargetJanuary 30th, 2023
  • JAK Inhibitors Increased VTE Risk in People with Inflammatory Disease
    JAK Inhibitors Increased VTE Risk in People with Inflammatory DiseaseDecember 30th, 2022
  • Join now to see all

Professional Memberships

Dr. Michael Garshick, Dr. Michael Garshick, MD, Dr. M Garshick, Dr. Michael Seth Garshick